A Study to Investigate the Safety, and Tolerability, of Topically Administered PF- 07295324 and PF-07259955, in Healthy Adults.  A Phase 1, Randomized, Double-Blind, Sponsor-Open, Vehicle-Controlled, First-in- Human, Multiple-Dose Study, to Investigate the Safety, Tolerability, and Pharmacokinetics, of Topically Administered PF-07295324 and PF-07259955, in Healthy Adult Participants.